Institutional Ownership
Axsome Therapeutics Inc
CUSIP 05464T104COMAXSMQ1 2026
13D / 13G Filings
24
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
9.5%
Max % of class reported
Institutional Holders
401
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
24 filings · latest Aug 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 14, 2025 | Rtw Investments, LP | 13G/A | 3.1% | 1.52M | SEC |
| 2 | May 15, 2025 | Rtw Investments, LP | 13G/A | 6.0% | 2.92M | SEC |
| 3 | Feb 14, 2025 | Rtw Investments, LP | 13G/A | 8.4% | 4.05M | SEC |
| 4 | Feb 14, 2024 | Fairmount Funds Management LLC | 13G/A | 4.9% | 2.36M | SEC |
| 5 | Feb 14, 2024 | Rtw Investments, LP | 13G/A | 9.5% | 4.49M | SEC |
| 6 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 7.8% | 3.70M | SEC |
| 7 | Jan 26, 2024 | Blackrock Inc. | 13G/A | 6.8% | 3.24M | SEC |
| 8 | Jul 7, 2023 | Fairmount Funds Management LLC | 13G | 5.0% | 2.34M | SEC |
| 9 | Feb 14, 2023 | Venrock Healthcare Capital Partners II, L.P. | 13G/A | — | — | SEC |
| 10 | Feb 14, 2023 | Pfm Health Sciences, LP | 13G/A | 3.2% | — | SEC |
14 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Axsome Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 3.91M | $661.35M |
| 2 | Fmr LLC | 1.57M | $264.85M |
| 3 | Invesco Ltd. | 1.30M | $219.33M |
| 4 | Geode Capital Management, LLC | 1.16M | $196.60M |
| 5 | Wellington Management Group LLP | 1.15M | $193.58M |
| 6 | Deep Track Capital, LP | 1.10M | $185.92M |
| 7 | State Street Corp | 986.8K | $166.79M |
| 8 | Assenagon Asset Management S.A. | 866.0K | $146.36M |
| 9 | Nomura Asset Management International Inc. | 812.8K | $137.38M |
| 10 | Adage Capital Partners Gp, L.L.C. | 737.6K | $124.67M |